Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Dinko Gonzalez Trotter"'
Autor:
Ruben Daniel de Ruiter, Esmée Botman, Bernd P. Teunissen, Adriaan Anthonius Lammertsma, Ronald Boellaard, Pieter G. Raijmakers, Lothar A. Schwarte, Jakko A. Nieuwenhuijzen, Dinko Gonzalez Trotter, Elisabeth Marelise W. Eekhoff, Maqsood Yaqub
Publikováno v:
Frontiers in Nuclear Medicine, Vol 4 (2024)
BackgroundFibrodysplasia Ossificans Progressiva (FOP) is a rare, genetic disease in which heterotopic bone is formed in muscles, tendons and ligaments throughout the body. Disease progression is variable over time and between individuals. 18F-fluorid
Externí odkaz:
https://doaj.org/article/08b45873b74a441c874634994026b7bb
Autor:
Maja Di Rocco, Eduardo Forleo-Neto, Robert Pignolo, Richard Keen, Philippe Orcel, Thomas Funck-Brentano, Christian Roux, Sami Kolta, Annalisa Madeo, Judith S Bubbear, Jacek Tabarkiewicz, Małgorzata Szczepanek, Javier Bachiller-Corral, Angela M Cheung, Kathryn M Dahir, Esmée Botman, Pieter G Raijmakers, Mona Al Mukaddam, Lianne Tile, Cynthia Portal-Celhay, Neena Sarkar, Peijie Hou, Bret Musser, Anita Boyapati, Kusha Mohammadi, Scott Mellis, Andrew J. Rankin, Aris N. Economides, Dinko Gonzalez Trotter, Gary Herman, Sarah J. O’Meara, Richard DelGizzi, David M. Weinreich, George D. Yancopolous, E. Marelise W. Eekhoff, Frederick S. Kaplan
BackgroundFibrodysplasia ossificans progressiva (FOP), an ultra-rare disorder caused by mutations in the gene encoding activin A receptor type 1 (ACVR1), is characterized by painful flare-ups and cumulative heterotopic ossification (HO). Garetosmab,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c882b21013c888887c75dbb8599f68a0
https://doi.org/10.1101/2023.01.11.23284254
https://doi.org/10.1101/2023.01.11.23284254
Autor:
Farshid Sepehrband, Prodromos Parasoglou, Dinko Gonzalez Trotter, Neelroop Parikshak, Oren Levy, Olivier Harari, Andreja Avbersek
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Brett Connolly, Stacey O'Malley, Michael Klimas, Jeffrey L. Evelhoch, Daniel Rubins, Caroline Ekblad, Marie A. Holahan, Mona Purcell, Paul McQuade, Eric D. Hostetler, Dinko Gonzalez Trotter, Fredrik Y. Frejd, Shu-An Lin, Xiangjun Meng, Pär Eklund, Joel Lindgren, Liza Gantert, Hyking Haley, Krista L. Getty
Publikováno v:
Molecular Imaging and Biology. 23:241-249
In vivo imaging of programmed death ligand 1 (PD-L1) during immunotherapy could potentially monitor changing PD-L1 expression and PD-L1 expression heterogeneity within and across tumors. Some protein constructs can be used for same-day positron emiss
Autor:
Pieter Koolwijk, Jan Maerten Smit, E. Marelise W. Eekhoff, Dimitra Micha, Nathalie Bravenboer, Coen Netelenbos, Adriaan A. Lammertsma, Wouter D. Lubbers, Pieter G. Raijmakers, Maqsood Yaqub, Ton Schoenmaker, Dinko Gonzalez Trotter, Bernd P. Teunissen, Teun J. de Vries, Lothar A. Schwarte, Esmée Botman, Gerard Pals
Publikováno v:
Botman, E, Raijmakers, P G H M, Yaqub, M, Teunissen, B, Netelenbos, C, Lubbers, W, Schwarte, L A, Micha, D, Bravenboer, N, Schoenmaker, T, de Vries, T J, Pals, G, Smit, J M, Koolwijk, P, Trotter, D G, Lammertsma, A A & Eekhoff, E M W 2019, ' Evolution of heterotopic bone in fibrodysplasia ossificans progressiva : An [18F]NaF PET/CT study ', Bone, vol. 124, pp. 1-6 . https://doi.org/10.1016/j.bone.2019.03.009
Botman, E, Raijmakers, P G H M, Yaqub, M, Teunissen, B, Netelenbos, C, Lubbers, W, Schwarte, L A, Micha, D, Bravenboer, N, Schoenmaker, T, de Vries, T J, Pals, G, Smit, J M, Koolwijk, P, Trotter, D G, Lammertsma, A A & Eekhoff, E M W 2019, ' Evolution of heterotopic bone in fibrodysplasia ossificans progressiva : An [F-18]NaF PET/CT study ', Bone, vol. 124, pp. 1-6 . https://doi.org/10.1016/j.bone.2019.03.009
Bone, 124, 1-6. Elsevier
Bone, 124, 1-6. Elsevier Inc.
Botman, E, Raijmakers, P G H M, Yaqub, M, Teunissen, B, Netelenbos, C, Lubbers, W, Schwarte, L A, Micha, D, Bravenboer, N, Schoenmaker, T, de Vries, T J, Pals, G, Smit, J M, Koolwijk, P, Trotter, D G, Lammertsma, A A & Eekhoff, E M W 2019, ' Evolution of heterotopic bone in fibrodysplasia ossificans progressiva : An [F-18]NaF PET/CT study ', Bone, vol. 124, pp. 1-6 . https://doi.org/10.1016/j.bone.2019.03.009
Bone, 124, 1-6. Elsevier
Bone, 124, 1-6. Elsevier Inc.
Fibrodysplasia ossificans progressiva (FOP) is a rare, autosomal dominant disorder characterized by heterotopic ossification (HO) in muscles, ligaments and tendons. Flare-ups often precede the formation of HO, resulting in immobilization of joints. D
Autor:
Judith Bubbear, Cynthia Portal-Celhay, Dinko Gonzalez Trotter, Eduardo Forleo-Neto, Robert J Sanchez, Małgorzata Szczepanek, Jacek Tabarkiewicz, Sami Kolta, Christian Roux, Esmée Botman, Annalisa Madeo, Scott Mellis, Thomas Funck-Brentano, Jennifer Mcginniss, Peijie Hou, E. Marelise W. Eekhoff, Angela M. Cheung, Lianne Tile, Aris N. Economides, Philippe Orcel, Richard Keen, Maja Di Rocco, Andrew J Rankin, Frederick S. Kaplan, Robert J. Pignolo, Neena Sarkar, Javier Bachiller-Corral, Mona Al Mukaddam, Kathryn Dahir
Publikováno v:
Journal of the Endocrine Society. 5:A251-A252
Background: Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare, autosomal dominant disorder driven by mutations in ACVR1 that render it responsive to Activin A. FOP is characterized by progressive heterotopic ossification (HO) and distressi
Autor:
Qingshou Chen, Daniel Rubins, Shu-An Lin, Xiangjun Meng, Hyking Haley, Philip S. Low, Dinko Gonzalez Trotter, Paul McQuade, Patricia Miller, Zhizhen Zeng
Publikováno v:
Molecular Pharmaceutics. 14:4353-4361
The folate receptor (FR) has been established as a promising target for imaging and therapy of cancer (FR-α), inflammation, and autoimmune diseases (FR-β). Several folate-based PET radiotracers have been reported in the literature, but an 18F- labe
Autor:
Brett Connolly, Elisabet Wahlberg, Paul McQuade, Linda Liang, Olof Widmark, Zhizhen Zeng, Dinko Gonzalez Trotter, Patricia Miller, Krista L. Getty, Daniel Rubins, Caroline Ekblad, Laurence Fayadat-Dilman, Eric D. Hostetler, Shu-An Lin, Xiangjun Meng, Jeffrey L. Evelhoch, Stacey O'Malley, Fredrik Y. Frejd, Michael Klimas
Publikováno v:
Journal of Nuclear Medicine. 58:1852-1857
Programmed death ligand 1 (PD-L1) is an immune regulatory ligand that binds to the T-cell immune check point programmed death 1. Tumor expression of PD-L1 is correlated with immune suppression and poor prognosis. It is also correlated with therapeuti
Autor:
Barry R Campbell, Catherine D. G. Hines, Jeffrey L. Evelhoch, Weisheng Zhang, Manishkumar Patel, Wenping Li, Dinko Gonzalez Trotter
Publikováno v:
ILAR Journal
It is well understood that the biopharmaceutical industry must improve efficiency along the path from laboratory concept to commercial product. In vivo imaging is recognized as a useful method to provide biomarkers for target engagement, treatment re
Autor:
Hyking Haley, Zhizhen Zeng, Paul McQuade, Xiangjun Meng, Shu An Lin, Qingshou Chen, Daniel Rubins, Philip S. Low, Dinko Gonzalez Trotter, Patricia Miller
Publikováno v:
Molecular Pharmaceutics. 13:1520-1527
Folate-receptor-targeted PET radiotracers can potentially serve as versatile imaging agents for the diagnosis, staging, and prediction of response to therapy of patients with folate-receptor (FR)-expressing cancers. Because current FR-targeted PET re